Speaker illustration

Doctor Laurence Lucats

Sanofi R&D, Chilly-Mazarin (France)

Systolic/diastolic effects of chronic treatment with omecamtiv mecarbil in minipigs with post-myocardial infarction Heart Failure with reduced Ejection Fraction (HFrEF)

Event: ESC CONGRESS 2019

Topic: Pharmacotherapy

Session: Basic science heart failure

Thumbnail

Prolonging systolic ejection time with omecamtiv is at the expense of ventricular filling and impairs ventricular active relaxation in rat

Event: ESC CONGRESS 2016

Topic: Basic mechanisms

Session: Heart failure/Left ventricular function

Thumbnail

This platform is supported by

logo Novo Nordisk